Monoclox (Cloxacillin)

Cloxacillin, the active ingredient in Monoclox, is a penicillinase-resistant penicillin presented as an oral tablet for oral use. It treats skin and soft‑tissue infections caused by penicillinase‑producing Staphylococcus aureus, primarily in adult patients.

GNH USA supplies Monoclox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Monoclox is a penicillinase‑resistant penicillin used to treat infections caused by susceptible bacteria. - Skin and soft‑tissue infections: effective against penicillinase‑producing Staphylococcus aureus. - Bone and joint infections: helps eradicate staphylococcal osteomyelitis. - Respiratory tract infections: used for staphylococcal pneumonia and bronchitis when indicated.

Cloxacillin may cause a range of adverse reactions, most of which are mild to moderate.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Rash: skin redness or mild itching. - Abdominal pain: discomfort in the stomach area. - Elevated liver enzymes: transient increase in hepatic markers.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Stevens‑Johnson syndrome: rare severe skin disorder. - Hemolytic anemia: destruction of red blood cells. - Neutropenia: marked reduction in neutrophil count. - Hepatitis: inflammation of the liver.

Before prescribing Monoclox, consider the following safety measures. - Allergy assessment: avoid use in patients with known penicillin hypersensitivity. - Renal function: adjust dose in severe renal impairment. - Hepatic function: monitor liver enzymes in patients with liver disease. - Pregnancy and lactation: use only if clearly needed; safety data are limited. - Drug monitoring: observe for signs of superinfection or Clostridioides difficile colitis. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Cloxacillin can affect the activity of several concomitant medicines.

Major Interactions (Avoid): - Methotrexate: increased toxicity due to reduced renal clearance. - Oral contraceptives: decreased efficacy, risk of unintended pregnancy. - Warfarin: enhanced anticoagulant effect, monitor INR closely.

Moderate Interactions (Monitor Closely): - Probenecid: decreases renal excretion of cloxacillin, may raise plasma levels. - Aminoglycosides: potential additive nephrotoxicity, monitor renal function. - Tetracyclines: antagonistic effect, may reduce antibacterial activity.